These stocks are likely to be in focus on January 18

On Monday, the frontline equity indices, i.e., Sensex and Nifty were volatile throughout the trading session and ended flat at the closing bell.

At close, the Sensex was up by 85.88 points or 0.14% at 61,308.91 and the Nifty was up by 52.35 points or 0.2% at 18,308.10.

On the BSE, about 2297 shares have advanced, 1308 shares declined, and 134 shares are unchanged.

These stocks are likely to be in focus for Tuesday's trading session -

Glenmark Pharmaceuticals Limited: Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval from the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the generic version of Lexiscan®1Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US, Inc. According to IQVIATM sales data for the 12-month period ending November 2021, the Lexiscan® Injection, 0.4 mg/5 mL (0.08 mg/mL) market achieved annual sales of approximately $659.9 million. The scrip was up by 0.14% at Rs 516.70 at market close.

KEC International Limited: KEC International, an Engineering, Procuring and Construction (EPC) major and an RPG Group Company, announced that the company has secured new orders of Rs. 1,112 crores across its various businesses: Transmission & Distribution (T&D), Civil, and Cables on Monday. The shares of KEC International were down by 1.26% at Rs 504.10, at market close on the BSE.

Tata Consultancy Services Limited:  Shares of TCS, hit an all-time high of Rs 4038.04 up by 1.7% on the BSE, on Monday. The stock of the IT services major was up by nearly 5% in the last 3 sessions, after the company exceeded its Q3FY22 estimates on the bourses. The stock of TCS was at Rs 4019.10, up by 1.26%, on the BSE.

52-week high stocks – From the BSE 200 pack, the stocks of Adani Green Energy, Grasim India, Larsen and Toubro, TCS, Infosys, and SBI Life Insurance Company have hit their 52-week high on Monday.